Bureau Veritas (BVI) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
7 Jan, 2026Executive summary
Achieved record 2024 results with revenue of €6.2 billion, up 6.4% year-over-year and 10.2% organically, driven by the LEAP | 28 strategy and strong global demand.
Adjusted operating profit rose 7.1% to €996.2 million, with a 16.0% margin, and adjusted net profit increased 8.0% to €620.7 million.
Free cash flow reached €843.3 million, up 27.9% year-over-year, with cash conversion at 114%.
Double-digit shareholder returns achieved via EPS growth of 8.7%, an 8.4% higher dividend, and a €200 million share buyback.
Strong execution of Leap 28 strategy, with broad-based growth across all business lines and regions.
Financial highlights
Revenue reached €6,240.9 million, up 6.4% reported and 10.2% organically year-over-year; Q4 organic growth was 9.6%.
Adjusted operating profit was €996.2 million (+7.1% y/y), with a margin of 16.0% (+11 bps reported, +38 bps at constant currency).
Adjusted net profit was €620.7 million (+8.0% y/y); adjusted EPS increased 8.7% to €1.38.
Free cash flow totaled €843.3 million (+27.9% y/y), representing 13.5% of revenue.
Net debt/EBITDA at 1.06x; strong liquidity with €1.2 billion cash and €600 million undrawn credit lines.
Outlook and guidance
For 2025, expects mid to high single-digit organic revenue growth, margin improvement at constant currency, and cash conversion above 90%.
LEAP | 28 targets 2024–2028: high single-digit total revenue CAGR, consistent margin improvement, double-digit returns, and strong cash conversion.
Strategy remains focused on LEAP | 28 ambitions, M&A acceleration, and consistent margin improvement.
Confident in delivering double-digit shareholder returns and maintaining disciplined capital allocation.
Latest events from Bureau Veritas
- 6.5% organic growth, margin up, strong cash flow, and positive outlook for 2026.BVI
Q4 202525 Feb 2026 - Record H1 2024: 9.2% organic growth, 15% margin, strong cash flow, and upgraded outlook.BVI
H1 20242 Feb 2026 - Q3 2024 revenue up 8.8% to €1,555m; 2024 organic growth outlook raised to 9–10%.BVI
Q3 2024 TU19 Jan 2026 - Q1 2025 revenue up 8.3% to €1,558.7m; robust growth and €200m share buyback announced.BVI
Q1 2025 TU20 Dec 2025 - H1 2025 saw 6.7% organic revenue growth, margin gains, and six strategic acquisitions.BVI
H1 20253 Nov 2025 - Q3 2025 delivered 6.3% organic growth and strong cash flow, with FY outlook reaffirmed.BVI
Q3 2025 TU23 Oct 2025 - Record financials, robust growth, and all AGM resolutions approved for 2025.BVI
AGM 202511 Jul 2025